Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • About us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • What’s next?
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
      • Job opportunities
    • Support Us
    • Keep in touch
    • Our annual accounts
  • Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Become a Corporate Charity Partner
    • Pelican Film Society
  • Shop
  • Events
  • Contact us

Leaving a Legacy

One thing is certain, your legacy, no matter the size, will make the world of difference to the life of someone affected by cancer.

Leaving a legacy will help to give more people the chance to take photographs with their family and friends after diagnosis and treatment.

We would be truly honoured to be part of your legacy and ask that you consider leaving a gift in your Will to the Pelican Cancer Foundation. Your gift can provide enduring support for our mission to help clinicians advance their skills and understanding of precision treatment for bowel cancer and secondary liver cancer, which will help colorectal cancer patients live for longer, with a better quality of life.

Every year in the UK over 40,000 people are diagnosed with bowel cancer. Additionally, many people will be diagnosed with secondary bowel cancer or metastases, meaning their primary cancer in the bowel has spread. 

Cancer continues to cause death and pain in the lives of many – affecting not only individuals but their friends and families too. Thanks to the work that has been done in research and education, a difference has been made, however there is much more that needs to be done.

Pelican’s work makes a fundamental difference to patients’ cancer journey – your support and legacy will directly contribute to our committed work to improve survival rates and help patients to live for longer, with a better quality of life.

 

 

 

 

 

Leaving a gift in your Will

When you want to write, update or amend your Will we recommend that you use a solicitor so that it reflects your exact wishes and contains the correct legal wording. If you already have a Will, you can add a Codicil which allows you to make amendments, without the need to re-write your Will. If you don’t already have a solicitor, The Law Society can help you find one in your area.

Whatever arrangements you choose to make, it can be a good idea to have a conversation with your family about your wishes which can avoid any surprises, disappointments, or conflict.

Leaving a gift, no matter the size – is precious and will contribute directly towards our work. There are several ways to leave a gift; you can leave a share of your estate, a fixed sum of money or a gift of a specific item.

Leaving a share of your estate after you have provided for your loved ones can be at any percentage you choose; as this gift is a proportion of your estate, it keeps up with inflation. A fixed sum is a gift of a specific amount of money and it can be advisable to review this from time to time as inflation can reduce its real value. A gift of a specific item can be something particular you wish to leave to the charity, such as a piece of jewellery, antique or property.

Leaving a legacy doesn’t affect your financial position today; it is a written promise that you will leave a set amount of your Estate to a single, or multiple, named charity of your choice.

It is possible that leaving a share of your estate to a charity could save in inheritance tax. However, this is a complicated area and specialist advice should always be taken from a solicitor, so you can consider all the options before making your Will.

Decide to leave a gift in your Will today. Let your legacy be part of Pelican’s worldwide legacy; please leave a gift in your Will to Pelican Cancer Foundation.

Leaving a gift, no matter the size, will be greatly valued and will contribute towards advancing our work and improving bowel cancer care.

  • £375 could pay for a patient to have an MRI scan within a research trial
  • £9,000 could fund a workshop to disseminate vital information to nurses, surgeons and other multidisciplinary clinicians
  • £12,000 could fund a clinical database to analyse patient data
  • £25,000 could fund seed funding for a new study
  • £50,000 could fund a Pelican surgical research fellow for a year
  • £250,000 could fund a national development programme tackling challenging topics, disseminate knowledge of innovative research and advances in precision treatment of colorectal cancer

 

“A massive big thank you to Pelican. These people are amazing. I feel really blessed to have them & their ground-breaking consultants & research behind me.” Anthony Whelan, bowel cancer patient, pictured with his family in Dec 2017

 

Research – influencing and enhancing tomorrow’s cancer treatment

Research is an essential element of our work and we focus on clinical trials – those that involve people – as they bring the latest treatments and approaches to today’s cancer patients. We focus on surgery as this cures more people of cancer than any other cancer intervention. Research is important in the evolution and improvement of tomorrow’s cancer treatment.

Education – conferences and national workshops; forging change to improve cancer care and treatments

Thanks to ongoing development and research, the care and treatment of cancer is constantly developing and continued learning is essential to share the latest advances in treatment, technology and surgical techniques. We run popular and ground-breaking courses and workshops for multi-disciplinary cancer specialists to share best practice and knowledge. 

Pelican Cancer Foundation Follow

Driving innovation and advancing surgery to help patients live well, for longer.

Pelican_Cancer
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
28 Nov

👇 Available now - http://pelicancancervideos.org
🎥Complexity and decision making for patients with low rectal cancer

Mr Mark Gudgeon, Professor Heald & Mr Moran
@MGudgeon @ProfessorHeald @Brendan92855812

Reply on Twitter 1597119096096784384 Retweet on Twitter 1597119096096784384 2 Like on Twitter 1597119096096784384 2 Twitter 1597119096096784384
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
26 Nov

👇 Available now - http://pelicancancervideos.org
🎥Complexity and decision making for patients with low rectal cancer

Mr Mark Gudgeon, Professor Heald & Mr Moran
@MGudgeon @ProfessorHeald @Brendan92855812

Reply on Twitter 1596393313757642752 Retweet on Twitter 1596393313757642752 1 Like on Twitter 1596393313757642752 1 Twitter 1596393313757642752
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
25 Nov

👇 Available now - http://pelicancancervideos.org
🎥Complexity and decision making for patients with low rectal cancer

Mr Mark Gudgeon, Professor Heald & Mr Moran
@MGudgeon @ProfessorHeald @Brendan92855812

Reply on Twitter 1596159243203350528 Retweet on Twitter 1596159243203350528 2 Like on Twitter 1596159243203350528 5 Twitter 1596159243203350528
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2023 · Outreach Pro Theme on Genesis Framework · WordPress · Log in